Geneva, April 20 -- International Clinical Trials Registry received information related to the study (NCT07525271) titled 'Trial Phase: Syndemic Adapted Medly Uganda' on April 6.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Yale University
Condition:
Mental Health
Intervention:
Device: Syndemic-Adapted Medly Uganda (SAMU)
Recruitment Status: Not recruiting
Phase: N/A
Date of First Enrollment: June 2026
Target Sample Size: 1500
Countries of Recruitment:
Uganda
To know more, visit https://clinicaltrials.gov/study/NCT07525271
Published by HT Digital Content Services with permission from Heal...